Advertisement

Topics

Otsuka America Pharmaceutical Incorporated Company Profile

07:46 EST 23rd November 2017 | BioPortfolio

Otsuka America Pharmaceutical, Inc. (OAPI) commercializes innovative pharmaceutical products in the U.S.

OAPI commercializes Otsuka-discovered and other healthcare products that serve unmet medical needs.

Location

2440 Research Boulevard
Rockville
MD
20850
United States of America

Contact

Phone: (301) 990-0030
Fax: (301) 212-8647
Email: mukeshp@otsuka.com


News Articles [621 Associated News Articles listed on BioPortfolio]

Bipolar I disorder drug from Otsuka, Lundbeck gets FDA nod

The once-monthly, extended-release injectable Abilify Maintena, or aripiprazole, from Otsuka Pharmaceutical and H.  -More- 

Mylan partners with Otsuka to commercialize tuberculosis med delamanid in high-burden countries

Subsidiaries of Mylan N.V. and Otsuka Pharmaceutical Co. ink an agreement to commercialize delamanid, branded as Deltyba by Otsuka, for the treatment of adults with pulmonary multidrug-resistant tuber...

BRIEF—Phase III data will support Otsuka's FDA resubmission

Tokyo’s Otsuka Pharmaceutical has presented detailed data from the Phase III REPRISE trial of tolvaptan…

FDA Approves Pill With Sensor Abilify MyCite; Otsuka Stock Up

Schizophrenia drug Abilify MyCite becomes the first drug approved in the U.S. with a sensor that digitally tracks if patients have ingested their medication. The U.S. Food and Drug Administration on M...

Otsuka Pharma And Lundbeck Announce Initiation Of Two Phase III Trials Of Brexpiprazole In Patients With Bipolar I Disorder

TOKYO & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 clinical trials to...

Medibio Limited: Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc.

-- Medibio will leverage its proprietary Digital Mental Health platform to process Otsuka clinical data with the goal of further clarifying the role of biomarker-based, objective measures in manage...

Health Canada Approves Otsuka and Lundbeck's Abilify Maintena (Aripiprazole Once Monthly) as Treatment for Bipolar I Disorder in Adults

Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for ABILIFY MAINTENA (aripiprazole for prolonged release injectable suspension), app...

Otsuka Holdings' medtech business to be transferred to medical device unit

Otsuka Holdings said it intends to move its medical device business to Otsuka Medical Devices, its wholly owned unit, effecti -More- 

PubMed Articles [917 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical care for patients of the third age in pharmacy organizations as a significant aspect of social gerontology.

There are questions in the article that study mutual relations of patients of elderly and senile age with pharmaceutical experts. It was revealed that pharmacy organizations are an important element i...

Critical review of surface-enhanced Raman spectroscopy applications in the pharmaceutical field.

Surface-enhanced Raman spectroscopy (SERS) is a sensitive analytical tool used in the pharmaceutical field in recent years. SERS keeps all the advantages of classical Raman spectroscopy while being is...

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.

Chapter issued by the United States Pharmacopeial Convention, Inc. is the standard for sterile compounding. It is designed to reduce the number of patient infections due to contaminated pharmaceutica...

Editorial Special Supplement of the European Journal of Pharmaceutical Sciences on the occasion of the retirement of Professor Meindert Danhof as Professor of Pharmacology at Leiden University.

Prioritization of diseases for the development of a pharmaceutical care service model in South Korea using the analytic hierarchy process
.

Drug therapy plays a critical role in most chronic diseases. Effectiveness of pharmaceutical care services in the improvement of clinical, social, or economic outcomes has been scientifically proven t...

Clinical Trials [578 Associated Clinical Trials listed on BioPortfolio]

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition

To compare the rate and extent of absorption of Aripiprazole Orally disintegrating tablets 10 mg of Chengdu Kanghong Pharmaceutical Group Co.,Ltd, China and ABILIFY (Aripiprazole) 10 mg or...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

The purpose of this study is to determine the safety and efficacy of Busulfan/FLAG (fludarabine, cytarabine and granulocyte colony-stimulating factor) Conditioning Regimen in Patients with...

Companies [2075 Associated Companies listed on BioPortfolio]

Otsuka America Pharmaceutical Incorporated

Otsuka America Pharmaceutical, Inc. (OAPI) commercializes innovative pharmaceutical products in the U.S. OAPI commercializes Otsuka-discovered and other healthcare products that serve unmet medical ne...

Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, innovative, fast-growing healthcare company that commercializes Otsuka-discovered and other product opportunities in North America, with a s...

Otsuka Pharmaceutical Co., Ltd./H. Lundbeck A/S

Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: “Otsuka – people creating new products for better health worldwide.” Otsuka rese...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck U.S.

Otsuka Pharmaceutical Company is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuk...

Otsuka Canada Pharmaceutical Inc.

Founded in 1964, Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy 'Otsuka-people creating new products for better health worldwide.â€...

More Information about "Otsuka America Pharmaceutical Incorporated" on BioPortfolio

We have published hundreds of Otsuka America Pharmaceutical Incorporated news stories on BioPortfolio along with dozens of Otsuka America Pharmaceutical Incorporated Clinical Trials and PubMed Articles about Otsuka America Pharmaceutical Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Otsuka America Pharmaceutical Incorporated Companies in our database. You can also find out about relevant Otsuka America Pharmaceutical Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record